Page last updated: 2024-11-03

prazosin and Multiple System Atrophy Syndrome

prazosin has been researched along with Multiple System Atrophy Syndrome in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Papay, R1
Zuscik, MJ1
Ross, SA1
Yun, J1
McCune, DF1
Gonzalez-Cabrera, P1
Gaivin, R1
Drazba, J1
Perez, DM1
Sakakibara, R1
Hattori, T1
Uchiyama, T1
Suenaga, T1
Takahashi, H1
Yamanishi, T1
Egoshi, K1
Sekita, N1

Trials

1 trial available for prazosin and Multiple System Atrophy Syndrome

ArticleYear
Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte.
    Journal of the autonomic nervous system, 2000, Mar-15, Volume: 79, Issue:2-3

    Topics: Adrenergic alpha-Antagonists; Aged; Female; Humans; Male; Middle Aged; Moxisylyte; Multiple System A

2000

Other Studies

1 other study available for prazosin and Multiple System Atrophy Syndrome

ArticleYear
Mice expressing the alpha(1B)-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation.
    Journal of neurochemistry, 2002, Volume: 83, Issue:3

    Topics: Adrenergic alpha-Antagonists; alpha-Synuclein; Animals; Body Weight; Brain; Cerebellum; Disease Mode

2002